DSCV.L vs NOVT
DSCV.L: A designer and manufacturer of customized electronic components and systems for industrial and high-reliability applications. NOVT: Novanta supplies precision motion control, optics, and specialty components to medical device, life science, and advanced industrial OEMs globally.
Side-by-side fundamentals
| Metric | DSCV.L | NOVT | Edge |
|---|---|---|---|
| Price as of 2026-08-03 close | £7.74 | $140.80 | |
| Market cap as of 2026-08-06 | n/a | $5.0B | |
| P/E as of 2026-08-06 | n/a | 104.24 | |
| Net margin as of 2026-08-06 | n/a | +5.3% | |
| Gross margin as of 2026-08-06 | n/a | +44.2% | |
| Operating margin as of 2026-08-06 | n/a | +8.9% | |
| ROE as of 2026-08-06 | n/a | +5.1% | |
| ROA as of 2026-08-06 | n/a | +3.2% | |
| Debt / equity as of 2026-08-06 | n/a | 0.19 | |
| Revenue growth (YoY) as of 2026-08-06 | n/a | +5.6% | |
| Revenue CAGR (3y) SEC XBRL | n/a | +4.4% | |
| Beta as of 2026-08-06 | n/a | 1.74 | |
| 1-year return as of 2026-08-03 close | +14.8% | +10.7% | DSCV.L higher |
Fundamentals: market data, as of 2026-08-06. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-03.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.